Douglas E. Feltner

Altered Brain Serotonin Homeostasis and Locomotor Insensitivity to 3,4-Methylenedioxymethamphetamine (“Ecstasy”) in Serotonin Transporter-Deficient Mic

Dietmar Bengel, Dennis L. Murphy, Anne M. Andrews et al. · Molecular Pharmacology · 1998 · 710 citations

Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli.

Wayne A. Marasco, Sem H. Phan, Henry C. Krutzsch et al. · Journal of Biological Chemistry · 1984 · 524 citations · Full text

Biosynthesis, Formyl Peptides, Biochemistry +15

Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial

John Day, Richard S. Finkel, Claudia A. Chiriboga et al. · The Lancet Neurology · 2021 · 449 citations

Rare Diseases, Spinal Cord Injury, Medicine +5

Pregabalin in Generalized Anxiety Disorder: A Placebo-Controlled Trial

Atul C. Pande, Jerri G. Crockatt, Douglas E. Feltner et al. · American Journal of Psychiatry · 2003 · 315 citations

Vocal Acoustic Biomarkers of Depression Severity and Treatment Response

James C. Mundt, Adam P. Vogel, Douglas E. Feltner et al. · Biological Psychiatry · 2012 · 313 citations

Psychiatry, Mood Symptom, Vocal Acoustic Biomarkers +6